A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia
A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia
Alessandria, IT, Italy2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy | Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-08-19 | NCT05977673 | |
| Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance | Actinomycetales infectious disease, Bacterial Infections and Mycoses, COVID-19, Clostridium infectious disease, Coronaviridae Infections, Corynebacterium Infections, DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Varicella Zoster Virus Infection, bacterial infectious disease, diphtheria, follicular lymphoma, gram-positive bacterial infections, herpes zoster, immune system disorder, immunoproliferative disorder, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, tetanus, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-06-26 | NCT06070961 |